Sensus Healthcare Second Quarter 2022 Financial Results Feature Revenue Growth of 124%

 Diluted EPS of $0.21 compares with $(0.02) for the year-ago quarter 

Affirms expectations for full-year profitability

Conference call begins at 4:30 p.m. Eastern time today

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2022.

Highlights from the second quarter of 2022 and recent weeks include the following (all comparisons are with the second quarter of 2021, unless otherwise indicated):

• Revenues were $12.1 million, up 124% from $5.4 million

• Net income was $3.5 million, or $0.21 per diluted share, compared with a net loss of $(0.3) million, or $(0.02) per share

• Adjusted EBITDA, a non-GAAP financial measure, was $4.7 million, compared with $(0.1) million

• Exited the quarter with $33.7 million in cash and cash equivalents

• Received orders for 10 TransDermal Infusion Systems™ from Hair Enhancement Centers to provide needleless injections of U.SK Under Skin’s hair-growth serum Skin Savers Hair™

• Shipped 5 units to Asia

• Shipped a second SRT System to Colorado State University College of Veterinary Medicine and Biomedical Sciences

• Expects continued growth in the third quarter and affirms expectations for full-year profitability

Sensus Healthcare will host an investment community conference call today beginning at 4:30 p.m. Eastern time, during which management will discuss financial results for the second quarter of 2022, provide a business update and answer questions. To access the conference call, please dial 888-390-3967 (U.S. and Canada) or 862-298-0702 (International). Please direct the operator to be connected to the Sensus Healthcare conference call. The call will be webcast live and can be accessed at the following link, which also may be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.

Following the conclusion of the conference call, a replay will be available by dialing 888-539-4649 (U.S. and Canada Toll Free) or 754-333-7735 (International). At the system prompt, dial the replay code 157325 followed by the # sign. Playback will begin automatically. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.

https://finance.yahoo.com/news/sensus-healthcare-second-quarter-2022-200500881.html